Overall
(N=98)
Age
<60 34 (34.7%)
≥60 64 (65.3%)
Gender
female 33 (33.7%)
male 65 (66.3%)
type
adenocarcinoma 78 (79.6%)
Others 3 (3.1%)
signet-ring cell carcinoma 17 (17.3%)
Tumor_size
<5 71 (72.4%)
≥5 26 (26.5%)
Missing 1 (1.0%)
Diff_degree
moderately differentiated 20 (20.4%)
poorly differentiated 74 (75.5%)
Missing 4 (4.1%)
Lauren_typing
Diffuse type 34 (34.7%)
intestinal type 33 (33.7%)
Mixed type 16 (16.3%)
Missing 15 (15.3%)
Vessel_carcinoma_embolus
No 40 (40.8%)
Yes 51 (52.0%)
Missing 7 (7.1%)
T_stage
1 32 (32.7%)
2 14 (14.3%)
3 11 (11.2%)
4 40 (40.8%)
Missing 1 (1.0%)
N_stage
0 42 (42.9%)
1 14 (14.3%)
2 12 (12.2%)
3 27 (27.6%)
Missing 3 (3.1%)
M_stage
0 81 (82.7%)
1 12 (12.2%)
Missing 5 (5.1%)
TNM
1 38 (38.8%)
2 9 (9.2%)
3 31 (31.6%)
4 19 (19.4%)
Missing 1 (1.0%)
MMR
dMMR 11 (11.2%)
pMMR 82 (83.7%)
Missing 5 (5.1%)
CA199
high 16 (16.3%)
low 80 (81.6%)
Missing 2 (2.0%)
CA724
high 24 (24.5%)
low 71 (72.4%)
Missing 3 (3.1%)
CEA
high 17 (17.3%)
low 79 (80.6%)
Missing 2 (2.0%)
Primary_site
corpus 24 (24.5%)
Lower 1/3 stomach 57 (58.2%)
Upper 1/3 stomach 15 (15.3%)
whole stomach 1 (1.0%)
Missing 1 (1.0%)